Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ethema HealthGRST EV-to-EBITDA is 20.34 as of Jul. 22, 2026. The stock has 2 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Ethema Health ranks worse than 76.48% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ethema Health's enterprise value is $32.61 Mil.
Ethema Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $1.60 Mil. Therefore, Ethema Health's EV-to-EBITDA for today is 20.34.
The historical rank and industry rank for Ethema Health's EV-to-EBITDA or its related term are showing as below:
GRST'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -19.96 Med: -1.81 Max: 137.5
Current: 20.34
During the past 13 years, the highest EV-to-EBITDA of Ethema Health was 137.50. The lowest was -19.96. And the median was -1.81.
GRST's EV-to-EBITDA is ranked worse than 76.48% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.075
vs GRST: 20.34
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Ethema Health (OTCPK:GRST) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ethema Health's PE Ratio (TTM) for today is calculated as:
Ethema Health's share price for today is $0.0001.
Ethema Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Ethema Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRST vs PAIYY, BACK, FCHS: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Ethema Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ethema Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ethema Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ethema Health's EV-to-EBITDA falls into.
Ethema Health's current Enterprise Value is $32.61 Mil.
Ethema Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.60 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ethema Health (GRST) has a EV-to-EBITDA of 20.34 as of Jul. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ethema Health. According to the industry distribution chart, Ethema Health ranks #387 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 76.5%.
Is Ethema Health's EV-to-EBITDA too high?
Ethema Health's current EV-to-EBITDA is 20.34. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.08. Ethema Health's value of 20.34 is 83.7% above this industry median. Based on the distribution chart, Ethema Health ranks #387 out of 506 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Ethema Health's EV-to-EBITDA compare to PAIYY and BACK?
According to the Healthcare Providers & Services industry distribution chart, Ethema Health ranks #387 out of 506 companies for EV-to-EBITDA. This places Ethema Health in the lower half of its industry. The industry median EV-to-EBITDA is 11.08. Ethema Health's value of 20.34 is 83.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.08, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ethema Health's current EV-to-EBITDA of 20.34 is 83.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ethema Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ethema Health's current EV-to-EBITDA is 20.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ethema Health stock overvalued right now?
Ethema Health (GRST) has a current EV-to-EBITDA of 20.34. The current EV-to-EBITDA is 20.34 and 83.7% above the Healthcare Providers & Services industry median of 11.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ethema Health (GRST), the current EV-to-EBITDA is 20.34 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ethema Health Corp is engaged in developing and operating medical clinics in Delray Beach Florida. It provides addiction and mental health treatment facilities. The company's operating segment includes Rehabilitation Services provided to customers. It generates maximum revenue from the In-Patient services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRST has been successfully added to your 
